ConcertAI, Caris Life Sciences to partner

By staff writers

January 9, 2023 -- Molecular science and technology firm ConcertAI and Caris Life Sciences have formed a partnership to develop translational and clinical development research platforms that will support drug development and therapeutics research.

The partnership will integrate Caris' genomic, transcriptomic, and proteomic database with ConcertAI's oncology, hematology, and urological cancer clinical data, the latter of which includes information on the treatment and outcomes of roughly 7 million patients, the company said.

Copyright © 2023

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking